# A nurse is assessing a 38-year-old patient who has been receiving treatment for pulmonary tuberculosis for 6 weeks. Which assessment finding would be the most significant indicator that the patient may be developing drug-resistant tuberculosis?

> source: MyMerci (mymerci.kr)  
> url: https://mymerci.kr/pages/nclex_q.php?qn_id=541354  
> language: ko  
> subject: Adult Health

## 문제

A nurse is assessing a 38-year-old patient who has been receiving treatment for pulmonary tuberculosis for 6 weeks. Which assessment finding would be the most significant indicator that the patient may be developing drug-resistant tuberculosis?

## 보기

1. Persistent low-grade fever of 99.2°F (37.3°C) in the evenings
2. Occasional nonproductive cough during morning hours
3. Mild fatigue and decreased appetite compared to baseline
4. Positive sputum culture with acid-fast bacilli after 4 weeks of treatment **✔ 정답**

**정답: 4**

## 해설

Persistent positive sputum culture after 4 weeks of treatment strongly indicates drug-resistant TB, requiring immediate evaluation. Other symptoms like low-grade fever or mild cough are less specific for drug resistance.

## 심화 해설

Understanding the Clinical Concern

When a patient is undergoing treatment for pulmonary tuberculosis, monitoring the response to therapy is critical. The goal of anti-tuberculosis therapy is not just symptomatic improvement but the eradication of Mycobacterium tuberculosis from the body. While symptoms like fever, cough, and fatigue may persist for a short period after starting effective treatment, the persistence or re-emergence of a positive sputum culture for acid-fast bacilli (AFB) is a direct microbiological marker of treatment failure. This failure can be due to non-adherence, malabsorption of drugs, or the development of drug resistance.

Why a Positive Sputum Culture is the Most Significant Indicator

The provided rationale emphasizes that modern tuberculosis management requires a precise characterization of the patient's clinical phenotype, which includes mycobacterial burden and drug susceptibility [1]. Monitoring treatment response is not based solely on clinical symptoms, as these can be subjective and slow to resolve. A positive sputum culture after 4 weeks of directly observed therapy is a definitive sign of ongoing bacterial replication. In the context of drug-resistant tuberculosis, the bacilli are not being killed by the standard first-line regimen. This finding necessitates an immediate re-evaluation of the treatment plan, including drug susceptibility testing (DST) to guide a shift to a second-line regimen, a principle central to phenotype-based precision medicine [1].

Analysis of Incorrect Options

The other options represent clinical symptoms that are less specific and can be expected during the initial phase of treatment or from the disease process itself, even when the drugs are effective.

- **Option 1:** A persistent low-grade fever of 99.2°F (37.3°C) can be part of the systemic inflammatory response that takes time to subside. It is a constitutional symptom, not a direct measure of treatment failure or drug resistance.

- **Option 2:** An occasional nonproductive cough is a common residual symptom. The cough reflex can persist due to airway irritation and healing inflammation long after the bacterial load has been significantly reduced.

- **Option 3:** Mild fatigue and decreased appetite are nonspecific symptoms of chronic illness and can also be side effects of the potent anti-tuberculosis medications themselves. They do not provide a reliable measure of the mycobacterial burden.

These symptoms represent the host's inflammatory response and clinical presentation, which, while important for defining the initial clinical phenotype, are not the most significant indicators for detecting drug resistance during treatment monitoring [1]. The gold standard for monitoring is the microbiological response, specifically the conversion of sputum cultures from positive to negative.

Connecting to Precision Medicine and Treatment Monitoring

The shift towards precision medicine in tuberculosis, as highlighted in the source material, relies on integrating multiple data points, including the mycobacterial burden [1]. A positive culture at 4 weeks directly indicates a high or persistent burden. This objective finding is a critical trigger for the clinician to suspect drug resistance and to employ advanced diagnostic tools, such as molecular drug susceptibility testing, to adapt the regimen. This approach moves beyond a one-size-fits-all treatment model, using microbiological failure as a key phenotype to identify patients who require a more intensive or tailored therapeutic strategy [1].

References (research sources)

- [1]Future Prospects for Using Clinical Phenotypes in Tuberculosis Precision Medicine-An Approach for Clinical Management.Research articleNiward K, Braian C, Svärdhagen G, Augustinsson D, Öhrnberg I, Ruslami R, Mpagama S, Svensson EM, Bruchfeld J, Alffenaar JW, Schön T. (2026) · DOI: 10.1093/cid/ciaf663

## 임상 시나리오

Monitoring TB Treatment ResponseDifferentiating Clinical Improvement from Microbiologic Cure
The primary goal of anti-TB therapy is microbiologic eradication. A positive sputum culture for acid-fast bacilli after 4 weeks of treatment is the most significant indicator of potential drug resistance or treatment failure, regardless of symptom improvement.

Clinical symptoms like fever, cough, and fatigue are unreliable markers of cure because they can persist for weeks even when the bacterial burden is decreasing. Only sputum culture conversion confirms a lack of ongoing bacterial replication.

CautionA positive culture at this stage mandates immediate drug susceptibility testing (DST) and re-evaluation of the regimen. Do not dismiss this finding as a slow response without ruling out multidrug-resistant TB (MDR-TB).

## 핵심 개념

- **Acid-Fast Bacilli (AFB)** — Mycobacteria that retain dye after acid-alcohol decolorization; detection in sputum indicates active TB disease.
- **Drug Susceptibility Testing (DST)** — Laboratory testing to determine which antibiotics will kill the specific strain of M. tuberculosis.
- **Directly Observed Therapy (DOT)** — A strategy where a healthcare worker watches the patient swallow each dose of anti-TB medication to ensure adherence.

## 같은 주제 문제

- [A 45-year-old patient with suspected pulmonary tuberculosis presents to the emergency depa…](https://mymerci.kr/pages/nclex_q.php?qn_id=541353)
- [A 65-year-old retired teacher presents to the emergency department with a 3-week history o…](https://mymerci.kr/pages/nclex_q.php?qn_id=541355)
- [A 45-year-old patient with suspected pulmonary tuberculosis presents to the emergency depa…](https://mymerci.kr/pages/nclex_q.php?qn_id=541356)
- [A nurse is caring for a patient with active pulmonary tuberculosis who has been on anti-tu…](https://mymerci.kr/pages/nclex_q.php?qn_id=541357)
- [A nurse is assessing a patient with active pulmonary tuberculosis who has been on anti-tub…](https://mymerci.kr/pages/nclex_q.php?qn_id=541358)
- [A nurse is caring for a patient with community-acquired pneumonia who has been on antibiot…](https://mymerci.kr/pages/nclex_q.php?qn_id=541359)
- [A nurse is caring for a patient with active pulmonary tuberculosis who has been receiving …](https://mymerci.kr/pages/nclex_q.php?qn_id=541360)
- [A nurse is caring for a patient with active pulmonary tuberculosis who has been on anti-tu…](https://mymerci.kr/pages/nclex_q.php?qn_id=541361)

---

More free questions: [기출문제](https://mymerci.kr/)

_학습 참고용입니다. 실제 임상은 최신 지침과 소속 기관 프로토콜을 따르세요._